Literature DB >> 1992769

Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro.

B Robaye1, R Mosselmans, W Fiers, J E Dumont, P Galand.   

Abstract

Tumor necrosis factor (TNF) is cytotoxic for many tumoral cell lines, whereas normal cells generally are considered resistant to this action. This study shows that this cytokine causes massive death of bovine endothelial cells in primary culture in a concentration- and time-dependent manner. Dying cells exhibit all the ultrastructural changes and the inter-nucleosome cleavage of DNA associated with apoptosis or 'programmed cell death.' This is the first report clearly showing a direct toxicity of TNF on endothelial cells and demonstrating that this results from the induction of the program of apoptotic death. Our observation raises the possibility that hemorrhagic necrosis in vivo, after treatment with TNF, might involve a direct cytocidal action on endothelial cells of the tumor neovasculature.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1992769      PMCID: PMC1886201     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

Review 1.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.

Authors:  J Le; J Vilcek
Journal:  Lab Invest       Date:  1987-03       Impact factor: 5.662

2.  Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation.

Authors:  S Araki; Y Shimada; K Kaji; H Hayashi
Journal:  Biochem Biophys Res Commun       Date:  1990-05-16       Impact factor: 3.575

3.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

4.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.

Authors:  A H Wyllie
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

5.  Physiological concentrations of ADP stimulate the release of prostacyclin from bovine aortic endothelial cells.

Authors:  A Van Coevorden; J M Boeynaems
Journal:  Prostaglandins       Date:  1984-04

6.  Hormonal regulation of cell death in rabbit uterine epithelium.

Authors:  S Nawaz; M P Lynch; P Galand; L E Gerschenson
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

7.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; W Fiers; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity.

Authors:  N Sato; T Goto; K Haranaka; N Satomi; H Nariuchi; Y Mano-Hirano; Y Sawasaki
Journal:  J Natl Cancer Inst       Date:  1986-06       Impact factor: 13.506

9.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

Review 10.  Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.

Authors:  J F Kerr; A H Wyllie; A R Currie
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

View more
  77 in total

1.  Anginex, a designed peptide that inhibits angiogenesis.

Authors:  A W Griffioen; D W van der Schaft; A F Barendsz-Janson; A Cox; H A Struijker Boudier; H F Hillen; K H Mayo
Journal:  Biochem J       Date:  2001-03-01       Impact factor: 3.857

2.  Intravenous immunoglobulin (IVIG) preparations induce apoptosis in TNF-alpha-stimulated endothelial cells via a mitochondria-dependent pathway.

Authors:  K Nakatani; S Takeshita; H Tsujimoto; I Sekine
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

3.  Effects of genotypically different strains of Helicobacter pylori on human microvascular endothelial cells in vitro.

Authors:  N Kalia; C Jones; D K Bardhan; M W Reed; J C Atherton; N J Brown
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

4.  Dichotomous actions of NF-kappaB signaling pathways in heart.

Authors:  Rimpy Dhingra; James A Shaw; Yaron Aviv; Lorrie A Kirshenbaum
Journal:  J Cardiovasc Transl Res       Date:  2010-05-25       Impact factor: 4.132

5.  Role of endonuclease activity and DNA fragmentation in Ca2+ ionophore A23187-mediated injury to rabbit isolated gastric mucosal cells.

Authors:  B L Tepperman; C W Lush; B D Soper
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 6.  Cell death in the cardiovascular system.

Authors:  Murray Clarke; Martin Bennett; Trevor Littlewood
Journal:  Heart       Date:  2006-03-17       Impact factor: 5.994

7.  Transcriptional control of viral gene therapy by cisplatin.

Authors:  James O Park; Carlos A Lopez; Vinay K Gupta; Charles K Brown; Helena J Mauceri; Thomas E Darga; Abdullah Manan; Samuel Hellman; Mitchell C Posner; Donald W Kufe; Ralph R Weichselbaum
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

8.  Eradication of metastatic tumour cells from lymph nodes by local administration of anti-CD3 antibody.

Authors:  Y Dohi; S Sunada; M Aoki; A Moriguchi; M Okabayashi; M Miyata; H Matsuda
Journal:  Cancer Immunol Immunother       Date:  1993-06       Impact factor: 6.968

9.  Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor.

Authors:  A D Blann; C N McCollum
Journal:  Inflammation       Date:  1998-10       Impact factor: 4.092

10.  Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I.

Authors:  C L Selinsky; K L Boroughs; W A Halsey; M D Howell
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.